MedTrace Logo

Application of Ectoin Allergy Nasal Spray in Comparison to Beclomethasone Nasal Spray

NCT02133053 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2014-05-07

No results posted yet for this study

Summary

This is a comparative, open label, parallel group, non interventional study to further demonstrate the effectiveness and tolerability of Ectoin® Allergy Nasal Spray. In addition the effectiveness and safety shall be compared to a Beclomethasone nasal spray. The patient applies Ectoin® Rhinitis Nasal Spray or Beclomethasone nasal spray according to the instructions for use. The observation takes place over a period of 14 days. Response to treatment is recorded at day 7 and day 14 by the physician and in daily by the patient in a dairy.

Conditions

  • Allergic Rhinitis

Interventions

OTHER

Medical Device, drug-like

Ectoin Allergy Nasal Spray

DRUG

Beclomethasone

Beclomethasone nasal spray

Sponsors & Collaborators

  • Bitop AG

    lead INDUSTRY

Principal Investigators

  • Uwe Sonnemann, MD · HNO Praxis Elmshorn

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-07-31
Completion
2011-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02133053 on ClinicalTrials.gov